Bosnia and Herzegovina, National Drug Report 2017

This report is part of the EMCDDA-IPA5 project ‘Further preparation of the IPA beneficiaries for their participation with the European Monitoring Centre for Drugs and Drug Addiction’ funded by the European Commission. It provides a top-level overview of the drug phenomenon in Bosnia and Herzegovina, covering drug supply, use and public health problems as well as drug policy and responses. It has been produced with the financial assistance of the European Union.